A self-described leading Asset Manager in Healthcare

HBM Healthcare Investments AG

HBM Partners

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Mineralys Therapeutics

Zosano Pharma

Nabriva Therapeutics

BioAtla

Galera Therapeutics

PTC Therapeutics

Pyxis Oncology

IVERIC bio

Acrivon Therapeutics

Ambrx

Aptinyx

Arcutis Biotherapeutics

Seer

Harmony Biosciences

Homology Medicines

Infinity Pharmaceuticals

Instil Bio

C4 Therapeutics

ChemoCentryx

IO Biotech

HBMP

COM:HBMPARTNERS

HBM Partners

market

industry

website

linkedin

peer of

invested in

Metrics